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Abstract
Background: Altered Na+ channel expression, enhanced excitability, and spontaneous activity
occur in nerve-injury and inflammatory models of pathological pain, through poorly understood
mechanisms. The cytokine GRO/KC (growth related oncogene; CXCL1) shows strong, rapid
upregulation in dorsal root ganglion in both nerve injury and inflammatory models. Neurons and
glia express its receptor (CXCR2). CXCL1 has well-known effects on immune cells, but little is
known about its direct effects on neurons.
Results: We report that GRO/KC incubation (1.5 nM, overnight) caused marked upregulation of
Na+ currents in acutely isolated small diameter rat (adult) sensory neurons in vitro. In both IB4-
positive and IB4-negative sensory neurons, TTX-resistant and TTX-sensitive currents increased 2-
to 4 fold, without altered voltage dependence or kinetic changes. These effects required long
exposures, and were completely blocked by co-incubation with protein synthesis inhibitor
cycloheximide. Amplification of cDNA from the neuronal cultures showed that 3 Na channel
isoforms were predominant both before and after GRO/KC treatment (Nav 1.1, 1.7, and 1.8). TTX-
sensitive isoforms 1.1 and 1.7 significantly increased 2 – 3 fold after GRO/KC incubation, while 1.8
showed a trend towards increased expression. Current clamp experiments showed that GRO/KC
caused a marked increase in excitability, including resting potential depolarization, decreased
rheobase, and lower action potential threshold. Neurons acquired a striking ability to fire
repetitively; IB4-positive cells also showed marked broadening of action potentials.
Immunohistochemical labelling confirmed that the CXCR2 receptor was present in most neurons
both in dissociated cells and in DRG sections, as previously shown for neurons in the CNS.
Conclusion: Many studies on the role of chemokines in pain conditions have focused on their
rapid and indirect effects on neurons, via release of inflammatory mediators from immune and glial
cells. Our study suggests that GRO/KC may also have important pro-nociceptive effects via its
direct actions on sensory neurons, and may induce long-term changes that involve protein
synthesis.
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Background
Altered sodium channel expression in sensory neurons
contributes to enhanced excitability and abnormal spon-
taneous activity after nerve injury or inflammation [1].
However, little is known about mechanisms of this
sodium channel regulation. Recent studies suggest impor-
tant roles for cytokines and chemokines in the nervous
system, in both neuropathic and inflammatory chronic
pain. They may regulate pain via direct effects on neurons
or glia, or via local release of modulators (e.g., prostaglan-
dins; bradykinin) from immune cells [2-6].
We recently described a rat pain model in which the sen-
sory neurons of the L4 and/or L5 dorsal root ganglia
(DRG) are inflamed by deposition of zymosan, which
stimulates a robust localized inflammatory response with-
out overt nerve injury. This caused abnormal spontaneous
activity, along with markedly increased sodium currents
in small diameter, primarily nociceptive DRG neurons, an
overall increase in excitability [7], and a very striking early
increase (15-fold after one day) in the chemokine GRO/
KC (growth-related oncogene/keratine-derived chemok-
ine; CXCL1) [8]. We observed similar large increases of
GRO/KC in the spinal nerve ligation model [9].
GRO/KC is best known for its role in neutrophil chemo-
taxis and degranulation early during inflammation. In
this regard its effects are similar to those of other CXC
family cytokines with an ELF motif, including interleukin-
8 (IL-8; CXCL8) in humans [10]. GRO/KC may also have
direct roles in the nervous system, including roles in path-
ological pain. Both GRO/KC and its primary receptor,
CXCR2 (IL-8Rb) are expressed in neurons and other cells
in the central nervous system, under normal and patho-
logical conditions [11-17]. Less is known about GRO/KC
in the peripheral nervous system. However, GRO/KC
stimulates calcium influx [18], and release of the pain-
related peptide calcitonin gene-related peptide (CGRP)
[19] from cultured neonatal DRG neurons. Levels of
GRO/KC in inflamed muscle tissue are well correlated
with nociceptive behavior [20]. Overall, these studies in
peripheral nervous system suggest a pro-nociceptive role
for GRO/KC (however, see [21]).
In view of the striking increases in GRO/KC observed in
DRG in several pain models, the evidence that this chem-
okine may play important roles in pathological pain, and
the relative dearth of information about its mechanisms
of action in pain processing pathways (especially in the
periphery), we initiated this study to examine effects of
GRO/KC on the properties of small diameter DRG neu-
rons. In light of our previous study showing marked
increases in Na+ currents and excitability following local
inflammation of the DRG [7], we focused on possible reg-
ulation of Na+ currents by GRO/KC in small diameter rat
DRG neurons in acute primary culture. Here we report
that overnight incubation with GRO/KC, but not acute
application, leads to increased excitability, 2- to 4 fold
increases in TTX-resistant and TTX-sensitive Na+ currents
without altered voltage dependence or kinetic changes,
and increases in mRNA abundance of Na channel iso-
forms that are already present in control cells. The increase
in Na+ currents required protein synthesis. The results sug-
gest that GRO/KC may have important pro-nociceptive
effects through direct effects on neurons.
Methods
Animals
Young female Sprague-Dawley rats (body weight 100–
150 g) were housed one or two per cage under a control-
led diurnal cycle of 12 h light and 12 h dark with free
access to water and food. The ambient environment was
maintained at constant temperature (22 ± 0.5°C) and rel-
ative humidity (60–70%). All the surgical procedures and
the experimental protocol were approved by the institu-
tional animal care and use committee of the University of
Cincinnati (Cincinnati, OH, USA).
Acute culture of sensory neurons
Rats were anesthetized by intraperitoneal injection of
pentobarbital sodium (50 mg/kg). The bilateral L4 and L5
DRGs were isolated and the sheath was carefully removed
in ice-cold normal Ringer solution. The connective tissue
was digested by exposure to Ca2+-free solution containing
1.0% collagenase II (Fisher Scientific) for 30 min at 37°C
followed by washout in normal Ringer solution for
another 10 min. DRGs were then dissociated by tritura-
tion with fire-polished Pasteur pipettes. DRG cells were
plated onto poly-D-lysine coated glass coverslips in
Medium199 (Sigma, St. Louis, MO, USA) containing 10%
heat-inactivated FBS and 1000 U/ml each of penicillin
and streptomycin. GRO/KC (rat recombinant, from Cell
Sciences, Canton, MA, USA) and/or cycloheximide
(Sigma) were added to the medium immediately after
plating, as indicated, and the DRG cells were incubated at
37°C (5% CO2 balance air) before recording. Recordings
were made within 30 hours of plating, and cells were
selected for recording based on diameter (< 25 μm) and
the absence of processes. Isolectin B4 (IB4) conjugated to
fluorescein isothiocyante (FITC) (1 μg/μl; Sigma) was
added to the culture medium for 30–60 min prior to start
of recording sessions to identify non-peptidergic IB4-pos-
tive and peptidergic IB4-negative neurons [22,23]. This
procedure has been previously shown not to affect the
currents measured [24]. Neurons showing a robust fluo-
rescence signal were classified as IB4-positive and those
displaying no signal at all, IB4-negative. In general, the flu-
orescence was not examined until after completion of cur-
rent recordings from each cell; i.e., IB4 binding was not
used as a criterion in selecting which cells to record. InMolecular Pain 2008, 4:38 http://www.molecularpain.com/content/4/1/38
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each individual experiment, we alternated between
recording from control and experimental coverslips
throughout the recording period. Every attempt was made
to compare control and experimental cells taken from the
same cultures, though in some cases it was not possible to
obtain data from all four types of cells (experimental and
control for both IB4-positive and IB4-negative) in a given
experiment, particularly when IB4 status was not deter-
mined until the end of the recording. Additional controls
for inter-animal variability are described in the Results
section. Once it had been well established that the propor-
tion of IB4-positive cells did not change with GRO/KC
exposure, IB4 binding was sometimes examined prior to
recording in order to ensure that approximately equal
numbers of each cell type were recorded in each experi-
ment.
Electrophysiological recording
After over-night culture (16–30 hours), coverslips were
transferred to a recording chamber. Whole cell voltage-
clamp recordings of small DRG neurons (diameter 15–25
μm) were conducted at room temperature with an Axo-
Patch-200B amplifier (Molecular Devices Corp, Union
City, CA, USA). Patch pipettes (2.5–4.0 MΩ) were fabri-
cated from borosilicate glass. Data were acquired on a
Pentium IV computer with the Clampex 8 program
(Molecular Devices Corp). The cell capacitance artifact
was cancelled by the nulling circuit of the recording
amplifier. Voltage errors were minimized by using ≥ 80%
series resistance compensation. The current was filtered at
5 kHz and sampled at 50 kHz. The recording chamber was
continuously perfused at room temperature with oxygen-
ated bath solution at a flow rate of 1–2 ml/min.
For the current-clamp study of excitability, we measured
the threshold current (rheobase), action potential (AP)
threshold, resting membrane potential, AP rising rate, AP
falling rate, afterhyperpolarization, and input resistance.
Any cells without AP were excluded from the study. Only
neurons that had stable membrane potential more nega-
tive than -45 mV after obtaining the whole cell configura-
tion were used for further study.
For the voltage-clamp study, total Na+ current was divided
into tetrodotoxin-resistant (TTX-R) and TTX-sensitive
(TTX-S) currents, using the method previously described
[7]. Briefly, in most experiments, the TTX-R currents were
isolated from the TTX-S currents by using a holding poten-
tial of -50 mV. The peak TTX-R current was measured at
each potential. Both TTX-R and TTX-S current were evoked
by a series of depolarizations from a holding potential of
-80 mV. The amplitude of the TTX-S current in each cell
was measured during depolarization to -10 mV from -80
mV, based on the distinct kinetic properties of the two cur-
rents. At this voltage, TTX-S current was measured as the
difference between the early peak current and the current
5 msec after the beginning of the depolarization, a time
window in which the TTX-S current essentially completely
inactivates but TTX-R current changes little. In experi-
ments in which TTX-S current evoked from -80 mV was
measured at additional voltages, a time window of 11
msec (at -20 mV) or 27 msec (at -30 mV) was used, as
determined in our previous studies using TTX to verify the
separation of the currents.
Solutions for recording action potentials
The normal bath solution for recording AP contained (in
mM) 130 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 10 HEPES, and
10 glucose. The pH was adjusted to 7.4 with NaOH, and
the osmolarity adjusted to ~300–310 mOsm with sucrose.
The pipette solution contained (in mM) 140 KCl, 1 CaCl2,
2 MgCl2, 11 EGTA, 10 HEPES, 10 NaCl and 2 Mg ATP. The
pH was adjusted to 7.3 with KOH, and osmolarity to
~290–300 mOsm with sucrose.
Solutions for recording sodium currents
Sodium currents were measured under a reduced sodium
gradient to reduce space clamp problems. The Na+ bath
solution contained (in mM) 30 NaOH, 110 TMA-Cl, 5
TEA-Cl, 2 MgCl2, 1 CaCl2, 0.1 CdCl2, 10 HEPES, and 10
glucose. The pH was adjusted to 7.4 with HCl, and the
osmolarity was adjusted to ~300–310 mOsm with
sucrose. The pipette solution contained (in mM) 140
CsCl, 5 NaOH, 2 MgCl2, 1 CaCl2, 11 EGTA, 10 HEPES, 2
Mg ATP, and 1 Li GTP. The pH was adjusted to 7.2 with
CsOH, and the osmolarity to ~290 – 300 mOsm with
sucrose. Voltages were not corrected for liquid junction
potentials, which were calculated to be < 10 mV in all
cases.
Immunohistochemical staining of GRO/KC receptor 
CXCR2 in sectioned DRG tissue
Rats were anesthetized and fixed by perfusing 200–300 ml
of Zamboni's fixative (4% paraformaldehyde in 0.1 M
phosphate buffer, pH = 7.4) through the left ventricle of
the heart. The bilateral L4/L5 DRGs were removed and
post-fixed in the perfusion fixative for 2 hours at room
temperature. The ganglia were horizontally sectioned with
a cryostat at a thickness of 8 μm. Tissue sections were incu-
bated in polyclonal rabbit anti-rat antibody to CXCR2
(Santa Cruz Biotechnology, Santa Cruz, CA) at a dilution
of 1:200 overnight at 4°C, followed by reaction with sec-
ondary antibody Alexa Fluor 594 goat anti-rabbit IgG
(H+L) (1:1000, Invitrogen, Carlsbad, CA) for 1 hour.
Immunohistochemical staining of GRO/KC receptor 
CXCR2 in dissociated DRG cells
DRG cells from L4/L5 spinal levels were removed from
rats, and neurons were isolated and cultured overnight.
The cultured cells were fixed with 4% paraformaldeyhdeMolecular Pain 2008, 4:38 http://www.molecularpain.com/content/4/1/38
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for 30 min at room temperature, washed in ice cold ace-
tone for 1 min, and permeablized with 1% Triton for 10
min. The cells were then incubated with antibody to
CXCR2 (1:100, Santa Cruz Biotechnology) and neuronal
marker anti-NeuN (1:100, Milipore, Billerica, MA) for 2
hours followed by incubation in secondary antibody con-
jugated to Alexa Fluor 594(1:1000, Milipore, Billerica,
MA) for 1 hour. After drying, the cells were mounted on
coverslips with Vector Hard Set mounting medium (Vec-
tor Laboratories Inc., Burlingame, CA, USA). In some
experiments, IB4 conjugated to FITC (1 μg/μl), instead of
anti-NeuN antibody, was added to the culture medium
for 30 min before switching to the primary antibody, to
identify IB4-positive and IB4 negative neurons. The
immunoreactive products were visualized using a confo-
cal microscope and Slidebook 4.1 imaging acquisition
software (Intelligent Imaging Innovations, Denver, CO,
USA).
Western blot analysis of CXCR2 in protein extracted from 
DRG
Western blot analysis was employed to confirm that the
CXCR2 antibody used for immunohistochemistry recog-
nized protein in the DRG of the size expected for CXCR2.
Bilateral L4/L5 DRGs were isolated and homogenized in
RIPA lysis buffer (0.5 M Tris-HCl, pH 7.4, 1.5 M NaCl,
2.5% deoxycholic acid, 10% NP-40, and 10 mM EDTA)
(Millipore, Billerica, MA) supplemented just before run-
ning the assay with a protease and phosphatase inhibitor
cocktail (100 μl of aprotinin, leupeptin, and pepstatin;
500 μl of PMSF, Na3VO4, and NaF) (Pierce, Rockford, IL,
USA) followed by centrifugation at 4 °C for 40 min. Sam-
ples (15 μg of total protein per lane) were subjected to
sodium dodecyl sulfate polyacrylamide gel electrophore-
sis (SDS-PAGE) running in Tris-HEPES-SDS buffer
(Pierce, Rockford, IL) followed by electrophoretic transfer
to nitrocellulose membrane (Bio-Rad, Hercules, CA, USA)
in tris-glycine-SDS transfer buffer. Nonspecific binding
sites were blocked with 3% nonfat dry milk (Bio-Rad) in
Tween (0.1%)-phosphate-buffered saline (PBST) at room
temperature for 1 hour. The CXCR2 antibody (1:300,
Santa Cruz Biotechnology) was applied to the blot fol-
lowed by incubation with immunopure peroxidase conju-
gated goat anti-rabbit IgG (H+L) (1:20,000, Pierce,
Rockford, IL). The blot was developed by exposure to
blue-light-sensitive Hyperfilm ECL (GE Healthcare Bio-
Sciences Corp) using the enhanced Chemiluninescent
(ECL) Western Blotting Detection System (GE Healthcare
Bio-Sciences Corp., Piscataway, NJ).
Quantitative analysis of sodium channel subtype 
expression
Total RNA was isolated from DRG cultures under condi-
tions similar to those used in electrophysiological record-
ings, using a Stratagene Absolutely RNA Miniprep Kit
(Stratagene, La Jolla, CA, USA). Immediately after isola-
tion, RNA was transcribed into cDNA using an iScript
cDNA kit (Bio-Rad). Cells treated overnight with 1.5 nM
GRO/KC were compared with control cells from a sister
culture. Relative channel expression was determined by
quantitative PCR using a Stratagene MX-Pro 3005P. cDNA
samples were amplified in triplicate (10 min at 95°C, fol-
lowed by 40 cycles of 30 sec 95°C, 60 sec 60°C, then 60
sec 72°C with fluorescence measured at the end) in a 25
μl reaction volume (400 nM each forward and reverse
primers, SYBR green reaction mix (Roche Applied Science,
Indianapolis, IN)). Fluorescence was normalized with the
reference dye ROX, and gene expression was normalized
to the housekeeping gene hypoxanthine ribosyltrans-
ferase (HPRT; [25]), run on the same plate. Primers (Table
1) were selected using the Primer3 program [26] and were
designed to include exon-intron boundaries to minimize
contamination by genomic DNA. Care was also taken to
avoid regions of homology with other Na channels, and
primers were examined with an in silico virtual PCR pro-
gram to ensure that no other products were predicted
from rat cDNA or genomic DNA http://genome.ucsc.edu.
PCR products were verified by melting point analysis at
the end of each experiment and, during protocol develop-
ment, by gel electrophoresis. Template from control cells
was run side-by-side with template from GRO/KC-treated
cells from the same culture. The efficiencies of the ampli-
fication reactions were estimated directly from the ampli-
fication plots using the DART program and a correction
for efficiencies was included in the relative expression cal-
culations [27]. Efficiencies were generally in the range of
95 to 103% and were similar for control and GRO/KC
treated samples, and across experiments. Hence a single
efficiency value was used for control and GRO/KC sam-
ples for each gene in any given experiment. Efficiencies
were set to 100% for genes with low expression that
amplified only during the last few cycles and did not have
enough data points for the DART efficiency measurement;
low-expressing genes were not studied in quantitative
detail. With the exception of the efficiency estimate,
amplification data were analyzed using MxPRO software
(Stratagene) to determine values for amplification thresh-
old and relative expression.
Data analysis
Data were analyzed using Clampfit 9 (Molecular Devices
Corp), Graphpad Prism (GraphPad Software, Inc., San
Diego, CA, USA), and Origin 7 (Origin Lab Corp., North-
ampton, MA, USA). Currents were normalized by cell
capacitance. The ohmic portion of the observed peak Na+
currents was measured from current steps to -100 through
-60 mV and subtracted. Data are expressed as mean ±
standard error of the mean (SEM). Differences in propor-
tion of cells binding IB4 were examined with Fisher's exact
test. Statistical significance of differences between averageMolecular Pain 2008, 4:38 http://www.molecularpain.com/content/4/1/38
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values in experimental and control neurons were analyzed
by Student's t-test or, for data that were not normally dis-
tributed, the Mann-Whitney rank sum test, using SigmaS-
tat Software (Systat Software, Inc., San Jose, CA, USA). In
the case of multiple comparisons over a voltage range for
activation data, the data were analyzed by two-way
repeated measures ANOVA (RM ANOVA), with pairwise
multiple comparison (Holm-Sidak method) to determine
at which voltages the differences between experimental
and control cells were significant if an overall effect of
GRO/KC treatment was observed. ANOVA (or Kruskal-
Wallis test on ranks, for data not showing normal distri-
bution) was used to analyze experiments with more than
two experimental groups. Activation data was fitted to the
Boltzmann equation (Figure 1) was done using Graphpad
Prism software. Significance of fold-changes in relative Na
channel expression in qPCR experiments was done using
a ratio t-test. Significance was ascribed for p < 0.05.
Results
Incubation with GRO/KC enhances Na+ current density 
without affecting other parameters
Small diameter DRG neurons were acutely cultured and
incubated overnight with 1.5 nM rat (recombinant) GRO/
KC or vehicle. The Na+ currents were measured in small
diameter neurons with whole cell patch clamp tech-
niques. After incubation in GRO/KC, voltage-activated
Na+ currents had overall properties (except for amplitude)
similar to those we have previously described in cells cul-
tured from control and locally inflamed DRG [7]. The Na+
currents in both control and GRO/KC treated cells acti-
vated at -30 to -20 mV (Figure 1). Persistent Na+ currents
attributed in previous studies to the Nav 1.9 isoform,
which activate at potentials near -60 mV under recording
conditions similar to ours [28,29], were observed in nei-
ther control nor GRO/KC treated cells. We observed small
sustained inward currents -40 mV in less than 10% of
cells, and never observed inward currents at potentials of
-50 or -60 mV (Figure 1; compare to [28,29]). Na+ currents
from GRO/KC treated cells (like those previously
observed in control cells and inflamed cells) had a faster
component that was blocked by 50 nM tetrodotoxin (TTX;
n = 6 GRO/KC treated cells; data not shown) or by using
a holding potential of -50 mV (Figure 1 and [7]). TTX-
resistant currents, which have slower kinetics, could be
isolated by using a holding potential of -50 mV which
inactivated TTX-sensitive currents.
As shown in Figure 2, GRO/KC incubation (16 to 30
hours) significantly increased the density both TTX-R and
TTX-S currents. These effects were seen in both IB4-posi-
tive and IB4-negative neurons. These results are from 53
control cells (26 were IB4-positive) and 54 GRO/KC
treated cells (28 were IB4-positive). In order to ensure that
this primary finding was not confounded by inter-animal
variability, we also analyzed the subset of data in which
currents measured in control cells could be compared
with that measured in GRO/KC treated cells from the
same batch (animal), in side-by-side experiments. Statisti-
cal analysis similar to that shown in Figure 1 was then
conducted using the batch averages (n = 4) instead of the
individual values for each cell. Despite the much smaller
N, the increase in TTX-R current was still statistically sig-
nificant in both IB4-positive (overall p = 0.019) and IB4-
Table 1: Primers used for qPCR experiments:
Name Rat gene symbol Rat gene ID Rat mRNA reference Primers Forward, reverse Predicted size (bp) Position in mRNA
Nav 1.1 Scn1a 81574 NM_030875.1 atccgagtccgaagatagca 137 1817..1953
gtctcggggaaaacagtgag
Nav 1.2 Scn2a1 24766 NM_012647.1 cggagagttcgtcagtagcc 229 1661..1889
aagagagactggtgcggaga
Nav 1.3 Scn3a 81574 NM_013119.1 aacttggtgccatcaaatcc 182 4513..4334
cagattcacacccatgatgc
Nav 1.4 Scn4a 25722 NM_013178.1 caccgctcttctctgcttct 282 23..304
gtgggtgtcctggtcttgtt
Nav 1.5 Scn5a 25665 NM_013125.1 ttctagctcgaggcttctgc 132 727..858
tgcgtaaggctgagacattg
Nav 1.6 Scn8a 29710 NM_019266.2 tacagtggctacagcggcta 274 2008..2281
tgtttgtgaccacgctcatt
Nav 1.7 Scn9a 78956 NM_133289 gacagcttcttccagaggtgataata 215 1922..2024
ccatggtggacatttttgtct
Nav 1.8 Scn10a 29571 XM_001078257 cacggatgacaacaggtcac 151 1610..1760
gatcccgtcaggaaatgaga
Nav 1.9 Scn11a 29701 NM_019265 ggcagccaagtcaatctttc 233 679..911
gggccacagttgtgcttaat
HPRT Hprt 24465 NM_012583 gcagactttgctttccttgg 278 495..772
tactggccacatcaacaggaMolecular Pain 2008, 4:38 http://www.molecularpain.com/content/4/1/38
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negative (p = 0.002) cells. The GRO/KC induced increases
in TTX-S currents showed the same trends as shown in Fig-
ure 2, though these did not reach significance with the
smaller N value when batch averages were analyzed (p =
0.1 for IB4-negative cells and p = 0.2 for IB4-positive
cells). The proportion of IB4-positive cells was not signif-
icantly altered by GRO/KC treatment (p = 0.8, Fisher's
exact test).
The higher (2 – 3 fold) TTX-S current density observed in
IB4-negative compared to IB4-positive cells was signifi-
cant in both control cells (p = 0.03, Mann-Whitney test)
and GRO/KC treated cells (p = 0.02, Mann-Whitney test).
There was a tendency for the peak TTX-R current (at 0 mV)
to be higher in IB4-negative cells which however did not
reach significance in either control cells (28% higher, p =
0.16, Mann-Whitney test) or in GRO/KC treated cells
(32% higher, p = 0.19, t-test).
The voltage dependence of activation for the TTX-resistant
current was not significantly affected by GRO/KC incuba-
tion (Figure 3A) and was not different between IB4-posi-
tive and IB4-negative cells. The activation curve for the
combined data was well fit by a Boltzmann equation with
V1/2 = -7.3 mV and a slope factor of 5.7. The time course of
decay for the TTX-R current during depolarizing pulses
was also unaffected by GRO/KC (Figure 3B). Similarly, the
time constant for decay of the TTX-S current at -10 mV was
not affected by GRO/KC incubation (Figure 3C). The TTX-
sensitive current became too fast to accurately voltage
clamp at more positive potentials, so its activation curve
was not determined in these experiments. However, the
TTX-sensitive current observed during steps from -80 to -
10 mV or below, where it is readily kinetically separated
from the TTX-resistant current (see Methods), showed a
qualitatively similar threshold for activation after GRO/
KC incubation (see Figure 2C and 2D).
Lower doses of GRO/KC were also tested in similar exper-
iments. Figure 4 shows the Na+ current density measured
at two lower doses of GRO/KC, 0.28 and 0.06 nM. As
shown, only the highest dose tested, 1.5 nM, gave a signif-
icant increase over control values, In Figure 4, data from
control cells were obtained for the experiments at each
separate dose. However, similar results were obtained if
the data were analyzed by comparing current densities at
each individual dose to the combined control values.
Enhancement of Na+ currents by GRO/KC is blocked by 
protein synthesis inhibitor
We were unable to observe increases in Na+ currents fol-
lowing acute (5 minute) application of 1.5 nM GRO/KC
(n = 5 IB4-positive and 7 IB4-negative cells). The finding
that GRO/KC enhanced the magnitude of Na+ currents
without marked shifts in voltage dependence activation or
kinetics (Figure 2, 3), and was observed only after a period
of incubation, suggested that the primary effect was an
increased number of Na+ channels, and hence that protein
synthesis might be required. To test this idea, we con-
ducted experiments using the protein synthesis inhibitor
cycloheximide. The results are shown in Figure 5. In gen-
eral, cycloheximide prevented the GRO/KC-induced
increases in Na+  current density without significantly
affecting baseline current densities. In both IB4-positive
and IB4-negative cells, only the GRO/KC without CHX
group differed significantly, from all three other groups.
GRO/KC incubated cells have Na+ currents that are qualita- tively similar to those seen in control cells Figure 1
GRO/KC incubated cells have Na+ currents that are 
qualitatively similar to those seen in control cells. A. 
Examples of current traces elicited from holding potential of 
-80 mV (darker, smaller traces) or -50 mV. As in control 
cells, the currents elicited from -80 mV have a faster compo-
nent, which is TTX-sensitive (see text). B. Persistent Na+ 
currents activating at -60 to -50 mV were not observed. 
Average leak-subtracted steady state current is plotted 
against the step potential. Holding potential was -80 mV.Molecular Pain 2008, 4:38 http://www.molecularpain.com/content/4/1/38
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The Na channel expression profile indicates upregulation 
of previously expressed channel types
Nine different genes for voltage-gated Na channels have
been described, with Nav1.1 – Nav1.7 mediating TTX-sen-
sitive current and Nav 1.8 and 1.9 mediating TTX-resistant
currents [30]. A simple explanation for the observed
effects of GRO/KC on Na channel currents would be
enhanced expression of channels with properties similar
to those seen in control cells. As an initial test of this pos-
sibility, we used quantitative PCR methods to quantify
relative changes in the amounts of Na channel mRNA
present in DRG neurons after overnight incubation in 1.5
nM GRO/KC. Culture conditions were kept as close as
possible to those used for the electrophysiological experi-
Overnight incubation with GRO/KC (1.5 nM) increases Na+ current density Figure 2
Overnight incubation with GRO/KC (1.5 nM) increases Na+ current density. A. TTX-R current density significantly 
increased in IB4-negative cells after GRO/KC incubation. P < 0.0001 for overall effect. Individual voltages at which the differ-
ence between control and GRO/KC treated cells was significant are indicated by the * symbol (two-way RM ANOVA with 
Holm-Sidak method for Pairwise Multiple Comparisons). B. A similar but smaller enhancement of TTX-R current was 
observed in IB4-positive cells (overall p value = 0.0016). TTX-S current density measured at -30 to -10 mV as described in 
methods, also significantly increased after GRO/KC incubation in both IB4-negative (C; and IB4-positive cells (D). Data are 
from 9 cultures; N = 53 control cells and 54 GRO/KC treated cells.Molecular Pain 2008, 4:38 http://www.molecularpain.com/content/4/1/38
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ments. Expression data were normalized to that of the
housekeeping gene HPRT. Of the nine Na channels, 3
showed much higher expression relative to HPRT than the
others: Nav 1.1, 1.7, and 1.8 (Figure 6A). Nav 1.4 (a form
found primarily in skeletal muscle), and 1.5 (a form
found primarily in cardiac muscle), were undetectable or
showed product only during the final few cycles. Nav 1.9
(which is thought to mediate persistent Na currents in
nociceptors) was also very low abundance, with relative
expression on the order of 10-6 times that of Nav 1.8. In
contrast, in mRNA isolated from a whole DRG, we
observed Nav1.9 mRNA with an abundance similar to that
of Nav 1.8. This profile of expressed channels was grossly
similar both before and after GRO/KC treatment; no pre-
viously low abundance channels were markedly upregu-
lated by GRO/KC. The fold- increases in Nav 1.1, 1.7, and
1.8 were between 2 and 3 fold, roughly similar to the
observed increase in current densities (Figure 6B); this
measurement is less sensitive to the efficiency correction.
These fold-increases were significant except in the case of
Nav 1.8, which showed a nonsignificant trend to similarly
increase (p = 0.08).
Distinct effects of GRO/KC on the excitability of IB4-
positive and IB4-negative neurons
In order to determine the likely physiological effects of
GRO/KC, excitability parameters were measured after a
1.5 nM GRO/KC incubation similar to that used to study
Na+ currents. As shown in Table 2, the overall effect of
GRO/KC treatment was a marked increase in excitability,
including a reduced action potential threshold, depolar-
Figure 3
Overnight incubation with GRO/KC does not affect decay  time constants or activation of Na+ currents Figure 3
Overnight incubation with GRO/KC does not affect 
decay time constants or activation of Na+ currents. A. 
Activation data for the TTX-R current was fit by a standard 
Boltzmann equation. No differences were found in the fit 
parameters between the 4 experimental groups (p = 0.22). 
The plotted line represents the best fit to all the data, and 
has a V1/2 value of -7.3 mV and a slope factor of 5.7. B. Time 
constants for the decay of TTX-R current were obtained by 
fitting single exponentials to the falling phase of currents 
evoked from a holding potential of -50 mV. No significant dif-
ference between the two groups was observed (two-way RM 
ANOVA). C. Time constants for the TTX-S current at were 
obtained by fitting the decaying phase of the current with the 
sum of two exponentials. The slower of these corresponded 
to the time constant observed in the TTX-R current, and the 
faster time constant was used as the value of the TTX-S 
decay time constant. No significant difference between the 
two groups was observed (Mann-Whitney test, p = 0.18). 
Data from IB4-positive and IB4-negative cells were combined 
as no difference between these groups in decay time con-
stants was observed.Molecular Pain 2008, 4:38 http://www.molecularpain.com/content/4/1/38
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ized resting potential, and decreased rheobase which were
observed in both IB4-negative and IB4-positive cells.
Initially, the experiments shown in Table 2 were con-
ducted by injecting short-duration (80 msec) current
pulses, and it was evident that after GRO/KC incubation
many cells fired action potentials for the entire duration
of these short depolarizing pulses. In order to examine
this effect in more detail, subsequent experiments were
conducted using much longer (1 s) current pulses. As
shown in Figure 7, such long pulses demonstrated a strik-
ing ability for repetitive firing that developed after GRO/
KC incubation. In IB4-negative cells, multiple action
potentials (up to 27) could be observed during the 1 sec-
ond current injection, and these lasted throughout the
entire pulse. IB4-positive cells also acquired the ability to
fire throughout the 1 second current injection after GRO/
KC incubation. In this case the number of action poten-
tials per pulse did not increase as dramatically; rather, the
action potentials tended to become very broad (Figure 7B
and Table 2), though still continuing until the end of the
1 second current injection. The significant increase in
action potential width (68%) seen in IB4-positive cells in
Table 2 may be a conservative estimate, because those
measurements are from the first evoked action potential
and action potentials tended to broaden even more dur-
ing the course of a long depolarizing pulse (Figure 7B).
Lower doses of GRO/KC do not increase Na+ current den- sity Figure 4
Lower doses of GRO/KC do not increase Na+ current 
density. Current densities were measured as in Figure 1, 
after overnight exposure to the indicated concentration of 
GRO/KC. For each concentration tested, data have been 
normalized to the control values obtained in cells from the 
same cultures with no GRO/KC treatment. *, significantly dif-
ferent from control. TTX-R current at 0 mV was used for 
this analysis. N = 27 cells for 0.06 nM dose (plus 17 control 
cells from the same cultures); 10 cells for 0.28 nM dose (plus 
14 control cells), and 54 cells for 1.5 nM dose (plus 53 con-
trol cells).
Effect of the protein synthesis inhibitor cycloheximide (CHX)  on enhancement of Na+ currents by GRO/KC incubation Figure 5
Effect of the protein synthesis inhibitor cyclohex-
imide (CHX) on enhancement of Na+ currents by 
GRO/KC incubation. Cycloheximide (3.5 μM) or vehicle 
(DMSO) was added to cell cultures just before addition of 
1.5 nM GRO/KC or vehicle, and TTX-S and TTX-R Na cur-
rents were measured 16 to 30 hours later. *, significantly dif-
ferent from all other groups; #, significantly different from 
control (one-way ANOVA followed by Tukey's multiple 
comparison test). Data are from 1 set of experiments (3 cul-
tures) comparing 22 control and 29 CHX treated cells, and a 
second set of experiments (2 cultures) comparing 14 GRO/
KC treated cells with 22 GRO/KC + CHX treated cells. 
Additional data, from Figure 1, are included in the control 
and GRO/KC data groups. Analysis omitting this additional 
data gave similar results, except that the TTX-R current in 
IB4-positive cells showed no significant differences between 
groups.Molecular Pain 2008, 4:38 http://www.molecularpain.com/content/4/1/38
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CXCR2 is expressed in both IB4-positive and IB4-negative 
neurons
Almost all dissociated DRG neurons including IB4-posi-
tive and IB4-negative neurons displayed CXCR2 staining
(Figure 8A, B). In addition, CXCR2 staining was extremely
intense in a subset of DRG cells. The intensely stained cells
had an average diameter of 21.9 ± 0.9 μm (n = 3 rats) and
were all IB4-negative. However, the number of high
CXCR2 expressing cells was very small, approximately
2.4% of all DRG cells, making it likely that the other data
reported in this study have a very small contribution from
this subset of neurons with extremely high expression lev-
els.
In DRG sections, CXCR2 was expressed in most neurons,
whether small, medium, or large diameter (Figure 8C, D).
An antibody directed to the C terminus of CXCR2 (sup-
plier: Santa Cruz) displayed intense staining of plasma
membrane and, in some cells, the nuclear membrane,
with no immunoreactivity in the nucleoli. Although there
was no apparent difference in CXCR2 staining of the
plasma membrane between most small and large neu-
rons, a subset of small DRG neurons displayed very high
density staining, similar to observations made in the dis-
sociated cells. Sections or dissociated cells incubated with
primary antibody preabsorbed with 30 fold excess of anti-
gen did not show any immunoreactivity (Figure 8E). In
order to further validate the antibody used for the CXCR2
staining, we conducted western blot analysis of protein
extracted from whole DRGs. Using the same antibody
from Santa Cruz at 1:300 dilution, the western blot
showed a strong doublet of 58–66 kDa and a lighter stain-
ing band of 35 kDa. An example is shown in Figure 8F;
similar results were obtained in 3 replicate experiments.
Discussion
In this study we found that overnight incubation with
GRO/KC (CXCL1), a chemokine that is rapidly upregu-
lated in the DRG in several different models of chronic
pain, caused increased excitability and marked upregula-
tion of Na+ current amplitudes in acutely isolated small
diameter DRG neurons in short-term culture. This upreg-
ulation required protein synthesis. Many studies on the
role of chemokines in pain conditions, including GRO/
KC (e.g.,[31]), have focused on their indirect effects on
neurons, via stimulation of release of inflammatory medi-
ators from immune and glial cells that then act on sympa-
thetic and sensory neurons. Our study suggests that GRO/
KC might also have important pro-nociceptive effects via
its direct actions on sensory neurons. The majority of
small diameter DRG neurons are nociceptors. The striking
increase in excitability after GRO/KC incubation, includ-
ing the ability to fire continuously during long depolari-
zations, would be expected to profoundly increase the
sensitivity to painful stimuli in vivo – both by increasing
the sensitivity of nociceptors to stimuli, and by increasing
the release of excitatory neurotransmitters in the dorsal
horn. It will be important to conduct experiments to inter-
fere with GRO/KC production or action in the DRG in
vivo, to confirm the pro-nociceptive roles for this chem-
okine suggested by this in vitro study.
Expression of Na channels Nav1.1 through Nav 1.9 in cul- tured DRG cells before and after GRO/KC incubation Figure 6
Expression of Na channels Nav1.1 through Nav 1.9 in 
cultured DRG cells before and after GRO/KC incuba-
tion. cDNA template was reverse-transcribed from RNA 
that had been isolated from control cells and cells from the 
sister cultures treated overnight with GRO/KC (1.5 nM). 
Expression of each gene was normalized to that of the 
housekeeping gene HPRT in the same batch of cDNA, deter-
mined during the same PCR amplification. A, profile of Na 
channel expression relative to HPRT. B, fold-change in 
expression of the 3 highly expressed Na channels after GRO/
KC treatment. *, significantly different from control (= 1.0, 
dotted line), ratio t-test. Values shown are averages from 4 
separate cultures.Molecular Pain 2008, 4:38 http://www.molecularpain.com/content/4/1/38
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Our results have some interesting similarities to those
reported by Liu et al. [32], who found that chronic (24 h)
exposure of cultured small diameter capsaicin-sensitive
trigeminal neurons to another pro-inflammatory
cytokine, interleukin 1-β (IL-1β), led to a 67% increase in
TTX-S (but not the TTX-R) Na+ current, without changes in
voltage dependence. As in our study, acute applications
did not increase Na+ current (and in fact caused slight
decreases in the Na+ current), and the cytokine receptor
was shown to be expressed on the neurons.
GRO/KC actions are thought to be mediated by the
CXCR2 receptor. As discussed in the Introduction, the
presence of this receptor on neurons (including neonatal
DRG neurons in vitro) has been previously observed with
a variety of methods. The effects reported here are most
likely to be due to a direct effect of GRO/KC on the neu-
rons, because: (1) effects were obtained in low density,
acute cultures, in which non-neuronal cells were very
sparse and intercellular mediators would be diluted by the
culture medium; and (2) using an antibody to the CXCR2
receptor, we demonstrated that the receptor was present
on the membranes of virtually all of the small diameter
neurons in our cultures. Western blot analysis of DRG
proteins, using the same antibody, revealed a doublet
band at 58–66 kDa and a lighter band of 35 kDa. For com-
parison, Xiong et al. [33] reported a band of approxi-
mately 58 kDa in Western blots of CXCR2 receptor in rat
hippocampus. The human receptor, which has an almost
identical predicted molecular weight of 40.7 kDa based
on amino acid sequence (vs. 40.5 kDa for the rat recep-
tor), has been reported to have an apparent molecular
weight of 56 kDa when isolated from neutrophils, due to
the presence of 2 N-linked 9 kDa carbohydrate moieties
[34]. Interestingly, this same group reported additional
forms of the human receptor, of 38 and 40 kDa that were
shown to differ in their carbohydrate groups.
The inability of GRO/KC to increase Na+ currents after
acute application, or in the presence of cycloheximide,
provides evidence that protein synthesis is required for the
effect on Na+ currents. The simplest explanation would be
that additional Na+ channels are synthesized after GRO/
KC incubation, as this would be consistent with the obser-
vation that only the magnitudes of the currents are
altered, not their activation range or decay time constants.
Our measurements of Na channel subtype expression
were consistent with this view. However, we cannot
entirely rule out other possibilities such as synthesis of
proteins that modulate channels already present. The
CXCR2 receptor is a G-protein-coupled receptor that has
been shown to activate a number of different signalling
pathways in neurons, including intracellular Ca2+, inosi-
tol tris-phosphate, MAP kinases, and CREB (reviewed in
[35]). In turn all of these pathways can lead to enhanced
transcription and protein synthesis through a number of
signal transduction pathways. In addition, some G-pro-
tein coupled receptors, including the closely related
CXCR4 receptor, have been shown to be present in the
nucleus as well as on the plasma membrane, where they
are thought to activate nuclear effects through additional
pathways (for review, see [36]). This is particularly inter-
esting in light of our observation of nuclear staining for
CXCR2 in some cells in addition to plasma membrane
staining in DRG neurons. While artifactual nuclear stain-
ing can be a problem with immunohistochemical meth-
ods, this seems somewhat less likely given the observation
that not all nuclei showed staining in our specimens.
Table 2: Membrane properties of isolated control and GRO/KC treated neurons in whole cell current clamp experiments
Cell and AP Properties IB4-negative cells IB4-positive cells
Control GRO/KC Control GRO/KC
Number of Cells 26 22 25 18
Diameter, μm 20.0 ± 0.8 21.2 ± 0.7 22.8 ± 0.5 20.2 ± 0.9*
Cell Capacitance, pF 17.6 ± 1.3 20.0 ± 1.2 19.0 ± 1.3 16.8 ± 1.7*
Resting Potential, mV -63.0 ± 1.6 -56.0 ± 1.4** -64.6 ± 1.4 -55.4 ± 1.9 **
Input Resistance, MΩ 1244.0 ± 144.3 986.1 ± 99.4 1062.0 ± 64.6 1427.4 ± 92.3**
AP Rheobase, pA 60.4 ± 8.4 21.1 ± 2.1** 76.2 ± 14.2 51.1 ± 11.2*
AP Threshold, mV -19.7 ± 0.9 -28.6 ± 1.4** -16.6 ± 0.6 -25.4 ± 1.3**
AP Rising Rate, mV/ms 106.8 ± 9.6 112.5 ± 10.7 103.4 ± 8.8 102.4 ± 12.0
AP Falling Rate, mV/ms 49.7 ± 4.8 61.9 ± 7.3 43.4 ± 3.8 39.9 ± 5.0**
AP Amplitude, mV 64.8 ± 1.7 74.8 ± 1.8** 63.1 ± 1.9 71.1 ± 1.5 **
AP Duration, ms 6.6 ± 0.4 7.3 ± 0.5 8.3 ± 0.5 14.0 ± 1.0**
AHP Amplitude, mV 3.5 ± 0.5 5.9 ± 0.6 ** 3.0 ± 0.8 4.5 ± 0.7
AHP Duration, ms 10.8 ± 2.4 14.7 ± 0.8* 7.7 ± 1.7 9.9 ± 1.4
Values are mean ± SEM. AP, action potential; AHP, afterhyperpolarization. * P < 0.05, ** P < 0.01, comparing GRO/KC treated vs. Control cells 
with the same IB4 status (Student's t-test or Mann-Whitney test). Rheobase is defined as the smallest depolarizing current to elicit at least one 
action potential within 80 msec. Action potential parameters were measured on this first elicited action potential.Molecular Pain 2008, 4:38 http://www.molecularpain.com/content/4/1/38
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We initially identified GRO/KC as a cytokine that might
play important roles in pathological pain because it
showed marked early increases in a pain model in which
localized inflammation of the DRG is induced by
zymosan [8]. Using the same model, we found that local-
ized inflammation led to marked increases in TTX-S and
TTX-R currents in small diameter DRG neurons, as well as
increased excitability, as determined by patch clamp stud-
ies in acutely isolated neurons [7]. That study and the
present study have certain common findings: both local-
ized inflammation and GRO/KC incubation give striking
increases in the magnitude of TTX-S current in both IB4-
positive and IB4-negative cells, without obvious changes
in inactivation time constant or voltage dependence. Both
lead to increased excitability, though these effects are
larger for GRO/KC treatment. One difference is that local-
ized inflammation led to increased TTX-R current only in
IB4-positive cells, while GRO/KC incubation also
increased this current in IB4-negative cells. The compari-
son of these two studies suggests that GRO/KC elevations
Small diameter neurons acquire the ability to fire repetitively after GRO/KC incubation Figure 7
Small diameter neurons acquire the ability to fire repetitively after GRO/KC incubation. A, Examples of the volt-
age response to a 90 pA 1 second current injection in a control IB4-negative neuron (top) and in an IB4-negative neuron incu-
bated overnight in GRO/KC (1.5 nM) (bottom). B. Examples of the voltage response to a 50 pA current injection in control 
(top) and GRO/KC incubated (bottom) IB4-positive neurons. Same scale as A. C, D: Average number of action potentials dur-
ing a 1 second current injection as a function of current amplitude in IB4-negative (C) and IB4-positive (D) cells. *, significant 
difference between GRO/KC and control cells at the indicated current value (two-way RM ANOVA with Holm-Sidak post 
test). N = 8 to 14 cells per group; data combined from 3 different cultures.Molecular Pain 2008, 4:38 http://www.molecularpain.com/content/4/1/38
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in the localized inflammation model provide one plausi-
ble explanation for some, but not all of the changes in ion
currents and excitability observed in this model. We
observed effects on excitability and Na+ currents at a rela-
tively low GRO/KC concentration of 1.5 nM, which is well
within the physiological range for most peptide receptor
actions. In one study, GRO/KC-stimulated (acute) Ca2+
elevation in isolated DRG neurons could be observed at
GRO/KC concentrations of 6.4 nM but was not significant
at 1.2 nM [19]. In cells expressing cloned CXCR2 recep-
tors, the binding constant for GRO/KC was 0.2 nM [37].
Thus it seems plausible that the effects reported here could
occur in vivo.
The TTX-R currents described here, as in our previous
study, had characteristics attributed to the Nav1.8 isoform.
Our recording conditions would have minimized contri-
butions from the persistent current (thought to be medi-
ated by the Nav1.9 isoform) due to slow inactivation at
the holding potentials used, and/or because the current
may "washout" during whole cell patch clamp [28,38].
Other studies also suggest that the persistent current
would be quite small under our recording conditions
(adenosine triphosphate in the pipette, Cl- as the anion)
[29]. In our qPCR experiments we observed that the
Nav1.9 isoform was very low abundance under our culture
conditions, though it had levels similar to Nav 1.8 in
cDNA derived from whole DRG. Hence the lack of Nav 1.9
currents in our experiments may be related to the acute
culture process; some studies of the persistent current
used shorter culture times than we used in this study. The
TTX-S current in DRG neurons is mediated by a number
of different isoforms, which are not readily distinguished
electrophysiologically. Some of the excitability changes
we observed after GRO/KC incubation, such as resting
membrane depolarization and increased input resistance,
are not readily explained by the increased Na+ currents
observed in the voltage clamp experiments. Hence it is
highly likely that additional ion currents can be modu-
lated by GRO/KC. This was also true of localized inflam-
mation, which upregulates voltage activated K+ currents as
well as Na+ currents [7].
Conclusion
In summary, the pro-inflammatory cytokine GRO/KC
(CXCL1), which markedly increases in DRG during the
early phase of several models of pathological pain, may
exert important pro-nociceptive effects in part through its
direct actions on nociceptive neurons.
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